A Trial Evaluating the Efficacy and Safety of Tenecteplase Together With Unfractionated Heparin Prior to Early Percutaneous Coronary Intervention (PCI) as Compared to Standard Primary PCI in Patients With Acute Myocardial Infarction (ASSENT 4 PCI)

NCT00168792 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

1671

Enrollment

INDUSTRY

Sponsor class

Conditions

Myocardial Infarction

Interventions

DRUG: Tenecteplase
PROCEDURE: PCI

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]